−129
Kymera Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−153
FY23:
−103
FY24:
−195
FY25:
−233
Change from FY21 to FY25
millions USD
FY21:
−99.8
FY22:
20.5
FY23:
140
FY24:
−404
FY25:
−521
Change from FY21 to FY25
millions USD
FY21:
250
FY22:
153
FY23:
4.19
FY24:
609
FY25:
991
millions USD
FY21:
21.5
FY22:
20.4
FY23:
41.3
FY24:
10.3
FY25:
237
(positive)
Change from FY21 to FY25
millions USD
FY21:
−131
FY22:
−156
FY23:
−137
FY24:
−207
FY25:
−234
All amounts in millions USD